tiprankstipranks
Trending News
More News >
Shield Therapeutics PLC (GB:STX)
LSE:STX

Shield Therapeutics (STX) Revenue

Compare
37 Followers

Shield Therapeutics Revenue

Shield Therapeutics had a revenue of 16.54M in the quarter ending Jun 30, 2025, with 6.49%. This bring the company's revenue in the last twelve months to 32.07M, Decreased 27.65%. In the fiscal year ending Dec 31, 2024, Shield Therapeutics had annual revenue of 25.18M with 92.46% growth.
Revenue (ttm)
32.07M
Revenue Growth
93.48%
P/S Ratio
2.91
Revenue/Employee
£399,741
Employees
63
Market Cap
£73.26M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
25.18M12.10M+192.46%
Dec 31, 2023
13.09M7.59M+237.95%
Dec 31, 2022
5.50M3.98M+362.01%
Dec 31, 2021
1.52M-8.87M+14.62%
Dec 31, 2020
10.39M9.67M+1,444.65%
Dec 31, 2019
719.00K-11.16M+6.05%
Dec 31, 2018
11.88M11.24M+1,865.15%
Dec 31, 2017
637.00K333.00K+209.54%
Dec 31, 2016
304.00K